litlas
Log inCreate account

David Nemazee

Active 1983–2025

102
Papers
19,232
Citations
75
h-index
101
i10-index

Citations

Citations per year for David Nemazee1984: 2 citations1985: 5 citations1986: 6 citations1987: 12 citations1988: 10 citations1989: 22 citations1990: 12 citations1991: 30 citations1992: 17 citations1993: 39 citations1994: 48 citations1995: 57 citations1996: 57 citations1997: 75 citations1998: 107 citations1999: 98 citations2000: 114 citations2001: 92 citations2002: 58 citations2003: 92 citations2004: 114 citations2005: 89 citations2006: 120 citations2007: 133 citations2008: 138 citations2009: 128 citations2010: 128 citations2011: 102 citations2012: 96 citations2013: 84 citations2014: 73 citations2015: 81 citations2016: 103 citations2017: 126 citations2018: 130 citations2019: 389 citations2020: 735 citations2021: 1,089 citations2022: 694 citations2023: 402 citations2024: 563 citations2025: 274 citations2026: 7 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,622 citing papers, 38% of this breakdownChina: 566 citing papers, 8.2% of this breakdownUnited Kingdom: 436 citing papers, 6.3% of this breakdownGermany: 366 citing papers, 5.3% of this breakdownAustralia: 245 citing papers, 3.6% of this breakdownFrance: 218 citing papers, 3.2% of this breakdownCanada: 210 citing papers, 3.1% of this breakdownSwitzerland: 210 citing papers, 3% of this breakdownNetherlands: 193 citing papers, 2.8% of this breakdownJapan: 181 citing papers, 2.6% of this breakdownItaly: 149 citing papers, 2.2% of this breakdownSweden: 119 citing papers, 1.7% of this breakdown
0%38%Other 20%

Institutions

Fields

  • Medicine48%
  • Immunology and Microbiology33.9%
  • Biochemistry, Genetics and Molecular Biology15.2%
  • Neuroscience0.6%
  • Engineering0.6%
  • Environmental Science0.5%
  • Other1.2%

Topics

  • SARS-CoV-2 and COVID-19 Research10.7%
  • T-cell and B-cell Immunology9.7%
  • Immune Cell Function and Interaction7.7%
  • Monoclonal and Polyclonal Antibodies Research6.5%
  • Immunotherapy and Immune Responses6.3%
  • COVID-19 Clinical Research Studies4.6%
  • Other54.5%

Coauthors

All papers

Open in search
  1. Broadly neutralizing antibodies target the coronavirus fusion peptide

    Authors: Cherrelle Dacon, Courtney Tucker, Linghang Peng, Chang‐Chun D. Lee, Ting-Hui Lin, Meng Yuan, Yu Cong, Lingshu Wang, Lauren Purser, Jazmean K. Williams, Chul‐Woo Pyo, Ivan Košík, Zhe Hu, Ming Zhao, Divya Mohan, Andrew J. R. Cooper, Mary Peterson, Jeff Skinner, Saurabh Dixit, Erin Kollins, Louis Huzella, Donna L. Perry, Russell Byrum, Sanae Lembirik, David Drawbaugh, Brett Eaton, Yi Zhang, Eun Sung Yang, Man Chen, Kwanyee Leung, Rona Singer Weinberg, Amarendra Pegu, Daniel E. Geraghty, Edgar Davidson, Iyadh Douagi, Susan Moir, Jonathan W. Yewdell, Connie S. Schmaljohn, Peter D. Crompton, Michael R. Holbrook, David Nemazee, John R. Mascola, Ian A. Wilson, Joshua Tan - Science 2022 cited by 269

  2. Mechanisms of central tolerance for B cells

    Authors: David Nemazee - Nature reviews. Immunology 2017 cited by 512

  3. Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors

    Authors: Joseph G. Jardine, Jean‐Philippe Julien, Sergey Menis, Takayuki Ota, Oleksandr Kalyuzhniy, Andrew T. McGuire, Devin Sok, Po‐Ssu Huang, Skye MacPherson, Meaghan Jones, Travis Nieusma, John C. Mathison, David Baker, Andrew B. Ward, Dennis R. Burton, Leonidas Stamatatos, David Nemazee, Ian A. Wilson, William R. Schief - Science 2013 cited by 822

  4. Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease

    Authors: Pan-Pan Zhou, Ge Song, Hejun Liu, Meng Yuan, Wanting He, Nathan Beutler, Xueyong Zhu, Longping V. Tse, David R. Martinez, Alexandra Schäfer, Fabio Anzanello, Peter Yong, Linghang Peng, Katharina Dueker, Rami Musharrafieh, Sean Callaghan, Tazio Capozzola, Oliver Limbo, Mara Parren, Elijah Garcia, Stephen A. Rawlings, Davey M. Smith, David Nemazee, Joseph G. Jardine, Yana Safonova, Bryan Briney, Thomas F. Rogers, Ian A. Wilson, Ralph S. Baric, Lisa E. Gralinski, Dennis R. Burton, Raiees Andrabi - Immunity 2023 cited by 167

  5. Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model

    Authors: Thomas F. Rogers, Fangzhu Zhao, Deli Huang, Nathan Beutler, Alison Burns, Wanting He, Oliver Limbo, Chloe N. Smith, Ge Song, Jordan L. Woehl, Linlin Yang, Robert Abbott, Sean Callaghan, Elijah Garcia, Jonathan Hurtado, Mara Parren, Linghang Peng, Sydney I. Ramirez, James Ricketts, Michael J. Ricciardi, Stephen A. Rawlings, Nicholas C. Wu, Meng Yuan, Davey M. Smith, David Nemazee, John R. Teijaro, James E. Voss, Ian A. Wilson, Raiees Andrabi, Bryan Briney, Elise Landais, Devin Sok, Joseph G. Jardine, Dennis R. Burton - Science 2020 cited by 1,496

  6. Precursor Frequency and Affinity Determine B Cell Competitive Fitness in Germinal Centers, Tested with Germline-Targeting HIV Vaccine Immunogens

    Authors: Robert Abbott, Jeong Hyun Lee, Sergey Menis, Patrick Skog, Meghan Rossi, Takayuki Ota, Daniel W. Kulp, Deepika Bhullar, Oleksandr Kalyuzhniy, Colin Havenar‐Daughton, William R. Schief, David Nemazee, Shane Crotty - Immunity 2017 cited by 367

  7. Broad neutralization of SARS-related viruses by human monoclonal antibodies

    Authors: Anna Z. Wec, Daniel Wrapp, Andrew S. Herbert, Daniel P. Maurer, Denise Haslwanter, Mrunal Sakharkar, Rohit K. Jangra, M. Eugenia Dieterle, Asparouh Lilov, Deli Huang, Longping V. Tse, Nicole V. Johnson, Ching‐Lin Hsieh, Nianshuang Wang, Juergen H. Nett, Elizabeth Champney, Irina Burnina, Michael E. Brown, Shu Lin, Melanie Sinclair, Carl Johnson, Sarat Pudi, Robert H. Bortz, Ariel S. Wirchnianski, Ethan Laudermilch, Catalina Florez, J. Maximilian Fels, Cecilia M. O’Brien, Barney S. Graham, David Nemazee, Dennis R. Burton, Ralph S. Baric, James E. Voss, Kartik Chandran, John M. Dye, Jason S. McLellan, Laura M. Walker - Science 2020 cited by 647

  8. Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody

    Authors: C. Garrett Rappazzo, Longping V. Tse, Chengzi I. Kaku, Daniel Wrapp, Mrunal Sakharkar, Deli Huang, Laura M. Deveau, Thomas J. Yockachonis, Andrew S. Herbert, Michael B. Battles, Cecilia M. O’Brien, Michael E. Brown, James C. Geoghegan, Jonathan Belk, Linghang Peng, Linlin Yang, Yixuan J. Hou, Trevor Scobey, Dennis R. Burton, David Nemazee, John M. Dye, James E. Voss, Bronwyn M. Gunn, Jason S. McLellan, Ralph S. Baric, Lisa E. Gralinski, Laura M. Walker - Science 2021 cited by 392

  9. Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen

    Authors: Joseph G. Jardine, Takayuki Ota, Devin Sok, Matthias Pauthner, Daniel W. Kulp, Oleksandr Kalyuzhniy, Patrick Skog, Theresa C. Thinnes, Deepika Bhullar, Bryan Briney, Sergey Menis, Meaghan Jones, Mike Kubitz, Skye Spencer, Yumiko Adachi, Dennis R. Burton, William R. Schief, David Nemazee - Science 2015 cited by 439

  10. Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivo

    Authors: Max Medina-Ramírez, Fernando Garcés, Amelia Escolano, Patrick Skog, Steven W. de Taeye, Iván del Moral-Sánchez, Andrew T. McGuire, Anila Yasmeen, Anna‐Janina Behrens, Gabriel Ozorowski, Tom L.G.M. van den Kerkhof, Natalia T. Freund, Pia Dosenovic, Yuanzi Hua, Alexander D. Gitlin, Albert Cupo, Patricia van der Woude, Michael Golabek, Kwinten Sliepen, Tanya R. Blane, Neeltje A. Kootstra, Mariëlle J. van Breemen, Laura K. Pritchard, Robyn L. Stanfield, Max Crispin, Andrew B. Ward, Leonidas Stamatatos, Per Johan Klasse, John P. Moore, David Nemazee, Michel C. Nussenzweig, Ian A. Wilson, Rogier W. Sanders - The Journal of Experimental Medicine 2017 cited by 205

  11. Tailored Immunogens Direct Affinity Maturation toward HIV Neutralizing Antibodies

    Authors: Bryan Briney, Devin Sok, Joseph G. Jardine, Daniel W. Kulp, Patrick Skog, Sergey Menis, Ronald Jacak, Oleksandr Kalyuzhniy, Natalia de Val, Fabian Sesterhenn, Khoa Le, Alejandra Ramos, Meaghan Jones, Karen L. Saye-Francisco, Tanya R. Blane, Skye Spencer, Erik Georgeson, Xiaozhen Hu, Gabriel Ozorowski, Yumiko Adachi, Michael Kubitz, Anita Sarkar, Ian A. Wilson, Andrew B. Ward, David Nemazee, Dennis R. Burton, William R. Schief - Cell 2016 cited by 289

  12. PLD3 and PLD4 are single-stranded acid exonucleases that regulate endosomal nucleic-acid sensing

    Authors: Amanda L. Gavin, Deli Huang, Christoph Huber, Annica Mårtensson, Virginie Tardif, Patrick Skog, Tanya R. Blane, T Thinnes, Kent G. Osborn, Hayley S. Chong, Farnaz Kargaran, Phoebe Kimm, Armen Zeitjian, Rachel L. Sielski, Megan Briggs, Sebastian Schulz, Alessandro Zarpellon, Benjamin F. Cravatt, Ee Shan Pang, John R. Teijaro, Juan Carlos de la Torre, Meredith O’Keeffe, Hubertus Hochrein, Markus Daμμe, Luc Teyton, Brian R. Lawson, David Nemazee - Nature Immunology 2018 cited by 149

  13. In vivo engineered B cells secrete high titers of broadly neutralizing anti-HIV antibodies in mice

    Authors: Alessio D. Nahmad, Cícera R. Lazzarotto, Natalie Zelikson, Talia Kustin, Mary Tenuta, Deli Huang, Inbal Reuveni, Daniel Nataf, Yuval Raviv, Miriam Horovitz‐Fried, Iris Dotan, Yaron Carmi, Rina Rosin‐Arbesfeld, David Nemazee, James E. Voss, Adi Stern, Shengdar Q. Tsai, Adi Barzel - Nature Biotechnology 2022 cited by 95

  14. Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern

    Authors: Hyeseon Cho, Kristina Kay Gonzales-Wartz, Deli Huang, Meng Yuan, Mary Peterson, Janie Liang, Nathan Beutler, Jonathan L. Torres, Yu Cong, Elena Postnikova, Sandhya Bangaru, Chloe Adrienna Talana, Wei Shi, Eun Sung Yang, Yi Zhang, Kwanyee Leung, Lingshu Wang, Linghang Peng, Jeff Skinner, Shanping Li, Nicholas C. Wu, Hejun Liu, Cherrelle Dacon, Thomas P. Moyer, Melanie Cohen, Ming Zhao, F. Eun‐Hyung Lee, Rona Singer Weinberg, Iyadh Douagi, Robin Gross, Connie S. Schmaljohn, Amarendra Pegu, John R. Mascola, Michael R. Holbrook, David Nemazee, Thomas F. Rogers, Andrew B. Ward, Ian A. Wilson, Peter D. Crompton, Joshua Tan - Science Translational Medicine 2021 cited by 137

  15. B cells expressing authentic naive human VRC01-class BCRs can be recruited to germinal centers and affinity mature in multiple independent mouse models

    Authors: Deli Huang, Robert Abbott, Colin Havenar‐Daughton, Patrick Skog, Rita Al-Kolla, Bettina Gröschel, Tanya R. Blane, Sergey Menis, Jenny Tuyet Tran, Theresa C. Thinnes, Sabrina A. Volpi, Alessia Liguori, Torben Schiffner, Sophia M. Villegas, Oleksandr Kalyuzhniy, Mark Pintea, James E. Voss, Nicole Phelps, Ryan Tingle, Alberto R. Rodriguez, Greg Martin, Sergey Kupryianov, Allan C. deCamp, William R. Schief, David Nemazee, Shane Crotty - National Academy of Sciences, Proceedings of the National Academy of Sciences 2020 cited by 74

  16. Cleavage of DNA and RNA by PLD3 and PLD4 limits autoinflammatory triggering by multiple sensors

    Authors: Amanda L. Gavin, Deli Huang, Tanya R. Blane, T Thinnes, Yusuke Murakami, Ryutaro Fukui, Kensuke Miyake, David Nemazee - Nature Communications 2021 cited by 62

  17. Presenting native-like trimeric HIV-1 antigens with self-assembling nanoparticles

    Authors: Linling He, Natalia de Val, Charles D. Morris, Nemil Vora, T Thinnes, Leopold Kong, P. Azadnia, Devin Sok, Bin Zhou, Dennis R. Burton, Ian A. Wilson, David Nemazee, Andrew B. Ward, Jiang Zhu - Nature Communications 2016 cited by 197

  18. Rare, convergent antibodies targeting the stem helix broadly neutralize diverse betacoronaviruses

    Authors: Cherrelle Dacon, Linghang Peng, Ting-Hui Lin, Courtney Tucker, Chang‐Chun D. Lee, Cong Yu, Lingshu Wang, Lauren Purser, Andrew J. R. Cooper, Jazmean K. Williams, Chul‐Woo Pyo, Meng Yuan, Ivan Košík, Zhe Hu, Ming Zhao, Divya Mohan, Mary Peterson, Jeff Skinner, Saurabh Dixit, Erin Kollins, Louis Huzella, Donna L. Perry, Russell Byrum, Sanae Lembirik, Michael Murphy, Yi Zhang, Eun Sung Yang, Man Chen, Kwanyee Leung, Rona Singer Weinberg, Amarendra Pegu, Daniel E. Geraghty, Edgar Davidson, Benjamin J. Doranz, Iyadh Douagi, Susan Moir, Jonathan W. Yewdell, Connie S. Schmaljohn, Peter D. Crompton, John R. Mascola, Michael R. Holbrook, David Nemazee, Ian A. Wilson, Joshua Tan - Cell Host & Microbe 2022 cited by 65

  19. Immunogenicity of RNA Replicons Encoding HIV Env Immunogens Designed for Self-Assembly into Nanoparticles

    Authors: Mariane Melo, Ely Porter, Yuan Zhang, Murillo Silva, Na Li, Brian Dobosh, Alessia Liguori, Pat Skog, Elise Landais, Sergey Menis, Devin Sok, David Nemazee, William R. Schief, Ron Weiss, Darrell J. Irvine - Molecular Therapy 2019 cited by 91

  20. Receptor editing in self-reactive bone marrow B cells.

    Authors: Susan L. Tiegs, D. M. Russell, David Nemazee - The Journal of Experimental Medicine 1993 cited by 1,017

  21. Reprogramming the antigen specificity of B cells using genome-editing technologies

    Authors: James E. Voss, Alicia González-Martín, Raiees Andrabi, Roberta Fuller, Ben Murrell, Laura E. McCoy, Katelyn Porter, Deli Huang, Wenjuan Li, Devin Sok, Khoa Le, Bryan Briney, Morgan Chateau, Geoffrey L. Rogers, Lars Hangartner, Ann J. Feeney, David Nemazee, Paula M. Cannon, Dennis R. Burton - eLife 2019 cited by 101

  22. HIV-1 vaccine design through minimizing envelope metastability

    Authors: Linling He, Sonu Kumar, Joel D. Allen, Deli Huang, Xiaohe Lin, Colin Mann, Karen L. Saye-Francisco, Jeffrey Copps, Anita Sarkar, Gabrielle S. Blizard, Gabriel Ozorowski, Devin Sok, Max Crispin, Andrew B. Ward, David Nemazee, Dennis R. Burton, Ian A. Wilson, Jiang Zhu - Science Advances 2018 cited by 101

  23. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes

    Authors: David Nemazee, Kurt Bürki - Nature 1989 cited by 1,018

  24. Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivo

    Authors: Bao Duong, Hua Tian, Takayuki Ota, Gladys C. Completo, Shoufa Han, José Luis Vela, Miyo Ota, Michael Kubitz, Nicolai V. Bovin, James C. Paulson, David Nemazee - The Journal of Experimental Medicine 2009 cited by 175